Cargando…
Analysis of health related quality of life (HRQoL) of patients with clinically localized prostate cancer, one year after treatment with external beam radiotherapy (EBRT) alone versus EBRT and high dose rate brachytherapy (HDRBT)
PURPOSE: Prostate cancer is the leading form of cancer diagnosed among North American men. Most patients present with localized disease, which can be effectively treated with a variety of different modalities. These are associated with widely different acute and late effects, which can be both physi...
Autores principales: | Joseph, Kurian Jones, Alvi, Riaz, Skarsgard, David, Tonita, Jon, Pervez, Nadeem, Small, Cormac, Tai, Patricia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494997/ https://www.ncbi.nlm.nih.gov/pubmed/18627617 http://dx.doi.org/10.1186/1748-717X-3-20 |
Ejemplares similares
-
Comparative analysis of the prognosis of external beam radiation therapy (EBRT) and EBRT plus brachytherapy for glioblastoma multiforme: a SEER population-based study
por: Yang, Kai, et al.
Publicado: (2022) -
Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer
por: Moll, Matthias, et al.
Publicado: (2021) -
Technological Advancements in External Beam Radiation Therapy (EBRT): An Indispensable Tool for Cancer Treatment
por: Koka, Krishna, et al.
Publicado: (2022) -
Treatment of early stage vaginal cancer with EBRT and MRI-based intracavitary brachytherapy: A retrospective case review
por: Damast, Shari, et al.
Publicado: (2016) -
Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro
por: Gholami, Yaser H., et al.
Publicado: (2018)